# Plumbagin inhibits fungal growth, HMGB1/LOX-1 pathway and inflammatory factors in A. fumigatus keratitis

**Authors:** Fan Cong, Lingwen Gu, Jing Lin, Guibo Liu, Qian Wang, Lina Zhang, Menghui Chi, Qiang Xu, Guiqiu Zhao, Cui Li

PMC · DOI: 10.3389/fmicb.2024.1383509 · Frontiers in Microbiology · 2024-04-09

## TL;DR

Plumbagin reduces fungal growth and inflammation in A. fumigatus keratitis by targeting the HMGB1/LOX-1 pathway and disrupting fungal structures.

## Contribution

This study demonstrates plumbagin's novel antifungal and anti-inflammatory effects via HMGB1/LOX-1 pathway inhibition in A. fumigatus keratitis.

## Key findings

- Plumbagin inhibits A. fumigatus growth, spore adhesion, and biofilm formation.
- Plumbagin reduces pro-inflammatory cytokines and activates IL-10 in infected mice.
- Plumbagin disrupts fungal cell membranes and reverses HMGB1 agonist effects.

## Abstract

To investigate the anti-inflammatory and antifungal effects of plumbagin (PL) in Aspergillus fumigatus (A. fumigatus) keratitis, the minimum inhibitory concentration (MIC), time-killing curve, spore adhesion, crystal violet staining, calcium fluoride white staining, and Propidium Iodide (PI) staining were employed to assess the antifungal activity of PL in vitro against A. fumigatus. The cytotoxicity of PL was assessed using the Cell Counting Kit-8 (CCK8). The impact of PL on the expression of HMGB1, LOX-1, TNF-α, IL-1β, IL-6, IL-10 and ROS in A. fumigatus keratitis was investigated using RT-PCR, ELISA, Western blot, and Reactive oxygen species (ROS) assay. The therapeutic efficacy of PL against A. fumigatus keratitis was assessed through clinical scoring, plate counting, Immunofluorescence and Hematoxylin-Eosin (HE) staining. Finally, we found that PL inhibited the growth, spore adhesion, and biofilm formation of A. fumigatus and disrupted the integrity of its cell membrane and cell wall. PL decreased IL-6, TNF-α, and IL-1β levels while increasing IL-10 expression in fungi-infected mice corneas and peritoneal macrophages. Additionally, PL significantly attenuated the HMGB1/LOX-1 pathway while reversing the promoting effect of Boxb (an HMGB1 agonist) on HMGB1/LOX-1. Moreover, PL decreased the level of ROS. In vivo, clinical scores, neutrophil recruitment, and fungal burden were all significantly reduced in infected corneas treated with PL. In summary, the inflammatory process can be inhibited by PL through the regulation of the HMGB-1/LOX-1 pathway. Simultaneously, PL can exert antifungal effects by limiting fungal spore adhesion and biofilm formation, as well as causing destruction of cell membranes and walls.

## Linked entities

- **Genes:** HMGB1 (high mobility group box 1) [NCBI Gene 3146], OLR1 (oxidized low density lipoprotein receptor 1) [NCBI Gene 4973], TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], IL10 (interleukin 10) [NCBI Gene 3586], ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098]
- **Chemicals:** plumbagin (PubChem CID 10205), Calcium fluoride (PubChem CID 84512), Propidium Iodide (PubChem CID 4939), Boxb (PubChem CID 53477779)
- **Species:** Aspergillus fumigatus (taxon 746128)

## Full-text entities

- **Diseases:** fungal (MESH:D009181), infected (MESH:D007239), inflammatory (MESH:D007249), keratitis (MESH:D007634), cytotoxicity (MESH:D064420)
- **Chemicals:** PL (MESH:C014758), ROS (MESH:D017382), Hematoxylin (MESH:D006416), PI (MESH:D011419), calcium fluoride (MESH:D002124), crystal violet (MESH:D005840)
- **Species:** Aspergillus fumigatus (species) [taxon 746128], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11035880/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11035880/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC11035880/full.md

---
Source: https://tomesphere.com/paper/PMC11035880